- Home
- AIR vs EWTX Comparison
AIR vs EWTX Comparison
Compare AIR & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- EWTX
- Stock Information
- Founded
- AIR 1951
- EWTX 2017
- Country
- AIR United States
- EWTX United States
- Employees
- AIR N/A
- EWTX N/A
- Industry
- AIR Aerospace
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- AIR Industrials
- EWTX Health Care
- Exchange
- AIR Nasdaq
- EWTX Nasdaq
- Market Cap
- AIR 2.5B
- EWTX 2.7B
- IPO Year
- AIR 1988
- EWTX 2021
- Fundamental
- Price
- AIR $62.85
- EWTX $30.75
- Analyst Decision
- AIR Strong Buy
- EWTX Buy
- Analyst Count
- AIR 5
- EWTX 6
- Target Price
- AIR $81.00
- EWTX $44.83
- AVG Volume (30 Days)
- AIR 177.1K
- EWTX 762.1K
- Earning Date
- AIR 01-07-2025
- EWTX 11-07-2024
- Dividend Yield
- AIR N/A
- EWTX N/A
- EPS Growth
- AIR N/A
- EWTX N/A
- EPS
- AIR 1.81
- EWTX N/A
- Revenue
- AIR $2,430,900,000.00
- EWTX N/A
- Revenue This Year
- AIR $17.43
- EWTX N/A
- Revenue Next Year
- AIR $7.27
- EWTX N/A
- P/E Ratio
- AIR $34.76
- EWTX N/A
- Revenue Growth
- AIR 16.09
- EWTX N/A
- 52 Week Low
- AIR $54.71
- EWTX $8.00
- 52 Week High
- AIR $76.34
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- AIR 40.39
- EWTX 46.80
- Support Level
- AIR $62.59
- EWTX $27.00
- Resistance Level
- AIR $64.36
- EWTX $35.50
- Average True Range (ATR)
- AIR 1.62
- EWTX 2.36
- MACD
- AIR -0.82
- EWTX -0.10
- Stochastic Oscillator
- AIR 6.72
- EWTX 38.94
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.